Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2008-07-22
2008-07-22
Romeo, David S (Department: 1647)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S350000
Reexamination Certificate
active
07402566
ABSTRACT:
A potent peptide inhibitor (SuperSog) of TGF-β family growth factor signaling, peptide variants thereof and nucleotide coding sequences therefore are provided by the invention. The Super-Sog peptide comprises a fragment of theDrosophiliashort gastrulation (Sog) gene which includes the CR-1 cysteine-rich repeat of Sog. Methods and compositions for use of Super-Sog in therapeutic and diagnostic applications are also provided.
REFERENCES:
Bowie et al. Deciphering the message in protein sequences: tolerance to amino acid substitutions. Science, (Mar. 16, 1990) 247 (4948) 1306-10.
Ngo et al., in Protein Folding Problem and Tertiary Structure Prediction, Merz and Le Grand (Eds), Aug. 1994, Springer Verlag, pp. 433 and 492-495.
Biehs, B., et al., “TheDrosophila short gastrulationgene prevents Dpp from autoactivating and suppressing neurogenesis in the neuroectoderm,”Gene&Development(1996) 10:2922-2934.
Bier, E., “Anti-Neural-Inibition: A Conserved mechanism for Neural Induction,”CellMay 30, 1997; 89:681-684.
Cork, MJ, et al., “Genetic control of cytokines. Cytokine gene polymorphisms in alopecia areata,”Dermatol ClinOct. 1996;14(4):671-678.
Danilenko DM, et al., “Growth factors and cytokines in hair follicle development and cycling: recent insights from animal models and the potentials for clinical therapy,”Mol Med TodayNov. 1996;2(11):460-467.
François, V., et al., “Dorsal-ventral patterning of theDrosophilaembryo depends on a putative growth factor encoded by theshort gastrulationgene,”Genes&Development(1994) 8:2602-2616.
François, V., et al., “XenopuschordinandDrosophila short gastrulationGenes Encode Homologous Proteins Functioning in Dorsal-Ventral Axis Formation,” Letters to the Editor,CellJan. 13, 1995; 80:19-20.
Genbank Accession No. AA140772, Jan. 25, 1997.
Genbank Accession No. L35764, Dec. 22, 1994.
Hoffmann, R., et al., “Growth factor mRNA levels in alopecia areata before and after treatment with the contact allergen diphenylcyclopropenone,”Acta Derm VenereolJan. 1996; 76(1):17-20.
Honda, Y., et al, “Osteogenic protein-I stimulates mRNA levels of BMP-6 and decreases mRNA levels of BMP-2 and -4 in human osteosarcoma cells,”Calcif Tissue IntMar. 1997; 60(3):297-301.
Imai, R., et al., “Effects of cytokines, anti-cancer agents and coarcinogen on DNA synthesis in hair bulb cells,”J Dermatol SciApr. 1993;5(2):73-80.
King, LE Jr, et al., “Growth factor receptors and hair loss.”J Invest DermatolMay 1991;96(5):79S.
Konig, A., et al., “IFN-gamma-induced HLA-DR but not ICAM-1 expression on cultured dermal papilla cells is downregulated by TNF-alpha,”Arch Dermatol ResJul. 1997; 289(8): 466-470.
Kweon, Y., et al., “TheDrosophila decapentaplegicandshort gastrulationgenes function antagonistically during adult wing vein development,”Development(1996) 122:4033-4044.
Murillas, R., et al., “Expression of a dominant negative mutant of epidermal growth factor receptor in the epidermis of transgenic mice elicits striking alterations in hair follicle development and skin structure.”EMBO JNov. 1, 1995;14(21):5216-5223.
Nishitoh H., et al., “Identification of type I and type II serine/threonine kinase receptors for growth/differentiation factor-5,”J Biol ChemAug. 30, 1996; 271(35):21345-21352.
Philpott, MP, et al., “Cultured human hair follicles and growth factors,”J Invest DermatolMay 1995;104(5 Suppl)44S-45S.
Phippard, DJ, et al., “Regulation of Msx-1, Msx-2, Bmp-2 and Bmp-4 during foetal and postnatal mammary gland development,”DevelopmentSep. 1996; 122(9):2729-2737.
Sanchez-Carpintero, et al., “Role of neuropeptides in dermatology,”Rev NeurolSep. 1997;25 Suppl 3:S222-S231.
Schmidt, J., et al., “Drosophila short gastrulationinduces an ectopic axis inXenopus: evidence for conserved mechanisms of dorsal-ventral patterning,”Development(1995) 121:4319-4328.
Sturtevant, Mark A., et al., “Thespaltgene links the A/P compartment boundary to a linear adult structure in theDrosophilawing,”Development124, 21-32 (1997).
Wu, X., et al., “Analysis of the native murine bone morphogenetic protein serine threonine kinase type I receptor (ALK-3)”J. Cell PhysiolAug. 1996; 168(2):453-461.
Xu, RH, et al., “Differential regulation of neurogenesis by the two Xenopus GATA-1 genes,”Mol Cell BiolJan. 1997; 17(1):436-443.
Zavadil, J., et al., “Smad5, a tumor suppressor candidate at 5q31.1, is hemizygously lost and not mutated in the retained allele in human leukemia cell line HL60,”LeukemiaAug. 1997;11(8):1187-1192.
Marques et al., Production of a DPP activity gradient in the early Drosophila embryo through the opposing actions of the SOG and LTD proteins. Cell. 91(3): 417-426, 1997.
Sambrook et al. Molecular Cloning: A Laboratory Manual. Second edition. vols. 1, 2 and 3. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, New York, U.S.A. Nov. 1989. p. 11.20.
Bier Ethan
Yu Kweon
DLA Piper (US) LLP
Romeo David S
The Regents of the University of California
LandOfFree
Peptide inhibitor of TGF-β growth factors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptide inhibitor of TGF-β growth factors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide inhibitor of TGF-β growth factors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2801316